Compare
BioLife Solutions vs West Pharmaceutical Services (BLFS vs WST)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year BioLife Solutions (BLFS) returned +49.0% and West Pharmaceutical Services (WST) +41.0%; so far this year the figures are +59.7% and +45.3%.
West Pharmaceutical Services is the larger company by market value, about 14.7 times the size of BioLife Solutions.
On trailing earnings, BLFS trades at 33.0 times and WST at 44.9 times.
Revenue grew +25.4% at BLFS and +12.6% at WST over the last year.
BLFS pays no dividend. WST yields 0.22%.
Data as of the latest close. Not investment advice.
Relative performance
| BLFS | WST | |
|---|---|---|
| Price | $38.61 | $399.81 |
| 1-day | +3.51% | +1.87% |
| YTD | +59.68% | +45.31% |
| 1 year | +49.02% | +41.01% |
| 3 years | +174.80% | +24.29% |
| Market cap | $1.9B | $27.9B |
| P/E | 33.0 | 44.9 |
| P/S | 18.37 | 8.20 |
| P/B | 4.50 | 9.38 |
| Revenue growth | +25.40% | +12.60% |
| EPS growth | — | +32.00% |
| Gross margin % | 60.4 | 37.6 |
| Net margin % | 56.4 | 18.8 |
| ROE % | 13.8 | 21.5 |
| Debt / equity | 0.00 | 0.07 |
| FCF yield % | 0.8 | 1.6 |
| Dividend yield % | — | 0.22 |
| Beta | 1.12 | 0.66 |
| RSI (14) | 60.6 | 57.5 |
| Technical rating |